drugset / Trial / NCT01490736

Phase 1/2 Sequentially Staged Safety Study in Healthy Subjects and Subjects With Mild Acne

NCT01490736 ↗

Phase 1/2 Completed 129 enrolled Dermira, Inc.
NaSingle-groupTriple-blindTreatment

Summary

The purpose of this study is to determine the safety of photodynamic therapy (PDT) with lemuteporfin topical solution (LTS) in healthy subjects and subjects with mild acne.

Timeline

Start
2011-12
Primary completion
2013-03
Completion
2013-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Lemuteporfin Small molecule 1 % Topical

Indications